Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.

MLA

Bloy, Norma, et al. “Immunogenic Stress and Death of Cancer Cells: Contribution of Antigenicity vs Adjuvanticity to Immunosurveillance.” Immunological Reviews, vol. 280, no. 1, Nov. 2017, pp. 165–74. EBSCOhost, https://doi.org/10.1111/imr.12582.

APA

Bloy, N., Garcia, P., Laumont, C. M., Pitt, J. M., Sistigu, A., Stoll, G., Yamazaki, T., Bonneil, E., Buqué, A., Humeau, J., Drijfhout, J. W., Meurice, G., Walter, S., Fritsche, J., Weinschenk, T., Rammensee, H.-G., Melief, C., Thibault, P., Perreault, C., & Pol, J. (2017). Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunological Reviews, 280(1), 165–174. https://doi.org/10.1111/imr.12582

Chicago

Bloy, Norma, Pauline Garcia, Céline M. Laumont, Jonathan M. Pitt, Antonella Sistigu, Gautier Stoll, Takahiro Yamazaki, et al. 2017. “Immunogenic Stress and Death of Cancer Cells: Contribution of Antigenicity vs Adjuvanticity to Immunosurveillance.” Immunological Reviews 280 (1): 165–74. doi:10.1111/imr.12582.